Joyce A O'Shaughnessy
Baylor Scott & White The Heart Hospital · US Oncology Network · Baylor Scott and White University Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Joyce A O'Shaughnessy as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:52 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06517212 · Tirzepatide Weight Loss for MRD+ Early Breast CancerBaylor Research Institute · recruiting · Breast Cancer, Breast Neoplasms, Breast Cancers · principal investigator
- Early Ph1NCT06008275 · Neratinib in Combination With Ruxolitinib in Patients With mTNBCBaylor Research Institute · recruiting · Metastatic Triple-Negative Breast Carcinoma, Breast Cancer · principal investigator
- N/ANCT04875351 · Breast Cancer Index (BCI) RegistryBiotheranostics, Inc. · active not recruiting · Breast Cancer · principal investigator
- Ph2NCT04032080 · LY3023414 and Prexasertib in Metastatic Triple-negative Breast CancerBaylor Research Institute · completed · Triple Negative Breast Cancer · principal investigator
- Ph2NCT02229136 · Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by EverolimusUS Oncology Research · completed · Stomatitis, Oral Mucositis, Neoplasm of the Breast · principal investigator
- Ph2NCT02187991 · Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast CancerUS Oncology Research · completed · Breast Cancer, Breast Carcinoma, Breast Tumors · principal investigator
- Ph2NCT02000882 · STAR Cape+BKM120 MBC With Brain MetUS Oncology Research · completed · Brain Metastases, Breast Cancer, Metastatic Breast Cancer · principal investigator
- N/ANCT01111175 · Triple Negative Breast Cancer Biomarker StudyUS Oncology Research · completed · Metastatic Breast Cancer, Triple Negative Breast Cancer · principal investigator
- Ph2NCT01036113 · A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast CancerEnzon Pharmaceuticals, Inc. · terminated · Metastatic Breast Cancer · principal investigator
- Ph2NCT00248287 · PhII ICb With/Without Erbitux in MBC PtsUS Oncology Research · active not recruiting · Metastatic Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:52 UTC. The ranking covers the 200 most relevant of 42 PubMed records, and a shared surname and initials can bring in a namesake. All 42 on PubMed
- 588 citationsRCR 14.8
- Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer.N Engl J Med · 2024478 citationsRCR 61.6
- 431 citationsRCR 10.1
- 421 citationsRCR 9.6
- Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer.J Clin Oncol · 2006416 citationsRCR 8.7
- Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology).J Clin Oncol · 2017230 citationsRCR 6.9
- Phase II study of weekly albumin-bound paclitaxel for patients with metastatic breast cancer heavily pretreated with taxanes.Clin Breast Cancer · 2007133 citationsRCR 3.1
- Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy.Clin Breast Cancer · 200577 citationsRCR 2.1
- Phase II study of trastuzumab plus gemcitabine in chemotherapy-pretreated patients with metastatic breast cancer.Clin Breast Cancer · 200469 citationsRCR 1.5
- Phase I crossover study of paclitaxel with r-verapamil in patients with metastatic breast cancer.J Clin Oncol · 199667 citationsRCR 2.0